Neutrophil to lymphocyte ratio and future risk of venous thromboembolism and mortality: the Tromsø Study

• Gro Grimnes,
• Lars D. Horvei,
• Vladimir Tichelaar,
• Sigrid K. Brækkan,
• John-Bjarne Hansen

Affiliations

Gro Grimnes

K.G. Jebsen Thrombosis Research and Expertise Centre (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway;Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway

Lars D. Horvei

K.G. Jebsen Thrombosis Research and Expertise Centre (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway;Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway

Vladimir Tichelaar

K.G. Jebsen Thrombosis Research and Expertise Centre (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway;University Medical Center Groningen, The Netherlands

Sigrid K. Brækkan

K.G. Jebsen Thrombosis Research and Expertise Centre (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway;Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway

John-Bjarne Hansen

K.G. Jebsen Thrombosis Research and Expertise Centre (TREC), Department of Clinical Medicine, UiT-The Arctic University of Norway, Tromsø, Norway;Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway